Merit Medical Systems Long Term Debt 2010-2023 | MMSI

Merit Medical Systems long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
Merit Medical Systems Annual Long Term Debt
(Millions of US $)
2023 $823
2022 $187
2021 $234
2020 $344
2019 $432
2018 $373
2017 $259
2016 $314
2015 $198
2014 $214
2013 $239
2012 $228
2011 $31
2010 $82
2009 $
Merit Medical Systems Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $823
2023-09-30 $282
2023-06-30 $335
2023-03-31 $186
2022-12-31 $187
2022-09-30 $205
2022-06-30 $236
2022-03-31 $243
2021-12-31 $234
2021-09-30 $271
2021-06-30 $285
2021-03-31 $313
2020-12-31 $344
2020-09-30 $350
2020-06-30 $403
2020-03-31 $438
2019-12-31 $432
2019-09-30 $432
2019-06-30 $385
2019-03-31 $362
2018-12-31 $373
2018-09-30 $187
2018-06-30 $392
2018-03-31 $366
2017-12-31 $259
2017-09-30 $261
2017-06-30 $225
2017-03-31 $220
2016-12-31 $314
2016-09-30 $318
2016-06-30 $222
2016-03-31 $218
2015-12-31 $198
2015-09-30 $200
2015-06-30 $200
2015-03-31 $203
2014-12-31 $214
2014-09-30 $230
2014-06-30 $238
2014-03-31 $244
2013-12-31 $239
2013-09-30 $241
2013-06-30 $247
2013-03-31 $244
2012-12-31 $228
2012-09-30 $65
2012-06-30 $57
2012-03-31 $53
2011-12-31 $31
2011-09-30 $6
2011-06-30 $55
2011-03-31 $83
2010-12-31 $82
2010-09-30 $88
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.272B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
West Pharmaceutical Services (WST) United States $28.373B 47.97
Cardinal Health (CAH) United States $25.885B 15.56
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Labcorp (LH) United States $17.372B 14.84
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00